Loreto Carmona

Summary

Country: Spain

Publications

  1. doi request reprint Rheumatoid arthritis
    Loreto Carmona
    Research Unit, Spanish Society of Rheumatology, Calle Marqués del Duero, 5, 28001 Madrid, Spain
    Best Pract Res Clin Rheumatol 24:733-45. 2010
  2. ncbi request reprint Cancer in patients with rheumatic diseases exposed to TNF antagonists
    Loreto Carmona
    Research Unit, Sociedad Española de Reumatología, Madrid, Spain
    Semin Arthritis Rheum 41:71-80. 2011
  3. doi request reprint Tackling missing radiographic progression data: multiple imputation technique compared with inverse probability weights and complete case analysis
    Miguel A Descalzo
    Research Unit, Sociedad Española de Reumatología, Madrid, Spain
    Rheumatology (Oxford) 52:331-6. 2013
  4. doi request reprint Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0
    Loreto Carmona
    Research Unit, Spanish Society of Rheumatology, Madrid, Spain
    Rheumatology (Oxford) 50:85-92. 2011
  5. doi request reprint Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis
    Esperanza Naredo
    Hospital Severo Ochoa, Madrid, Spain
    Arthritis Rheum 58:2248-56. 2008
  6. ncbi request reprint Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis
    Lydia Abasolo
    Hospital Clinico San Carlos, Madrid, Spain
    Arthritis Rheum 57:335-42. 2007
  7. doi request reprint Prognostic factors in short-term disability due to musculoskeletal disorders
    Lydia Abasolo
    Hospital Clinico San Carlos, Madrid, Spain
    Arthritis Rheum 59:489-96. 2008
  8. ncbi request reprint Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population
    Lydia Abasolo
    Rheumatology Department, Hospital Clinico San Carlos, Madrid, Spain
    Semin Arthritis Rheum 37:388-97. 2008
  9. ncbi request reprint Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis
    Alejandro Balsa
    Rheumatology Unit, Hospital Universitario La Paz, Madrid, Spain
    J Rheumatol 31:40-6. 2004
  10. pmc All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
    Loreto Carmona
    Research Unit, Spanish Foundation of Rheumatology, Madrid, Spain
    Ann Rheum Dis 66:880-5. 2007

Collaborators

Detail Information

Publications41

  1. doi request reprint Rheumatoid arthritis
    Loreto Carmona
    Research Unit, Spanish Society of Rheumatology, Calle Marqués del Duero, 5, 28001 Madrid, Spain
    Best Pract Res Clin Rheumatol 24:733-45. 2010
    ..Age, sex, smoking, shared epitope and others correlate with its RA. The most important determinants of prognosis in RA are the severity at presentation and the management of the disease, both of which are subject to inequalities...
  2. ncbi request reprint Cancer in patients with rheumatic diseases exposed to TNF antagonists
    Loreto Carmona
    Research Unit, Sociedad Española de Reumatología, Madrid, Spain
    Semin Arthritis Rheum 41:71-80. 2011
    ..To describe the risk of cancer in patients exposed to tumor necrosis factor (TNF) antagonists...
  3. doi request reprint Tackling missing radiographic progression data: multiple imputation technique compared with inverse probability weights and complete case analysis
    Miguel A Descalzo
    Research Unit, Sociedad Española de Reumatología, Madrid, Spain
    Rheumatology (Oxford) 52:331-6. 2013
    ....
  4. doi request reprint Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0
    Loreto Carmona
    Research Unit, Spanish Society of Rheumatology, Madrid, Spain
    Rheumatology (Oxford) 50:85-92. 2011
    ..To compare the safety and retention rate of TNF antagonists used in approved indications (AIs) and non-AIs...
  5. doi request reprint Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis
    Esperanza Naredo
    Hospital Severo Ochoa, Madrid, Spain
    Arthritis Rheum 58:2248-56. 2008
    ..To evaluate the validity, responsiveness, and predictive value of power Doppler ultrasonography (PDUS) monitoring of response to tumor necrosis factor (TNF) blocking agents in rheumatoid arthritis (RA)...
  6. ncbi request reprint Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis
    Lydia Abasolo
    Hospital Clinico San Carlos, Madrid, Spain
    Arthritis Rheum 57:335-42. 2007
    ..To evaluate how an intervention program modifies the clinical course of work disability in musculoskeletal diagnoses...
  7. doi request reprint Prognostic factors in short-term disability due to musculoskeletal disorders
    Lydia Abasolo
    Hospital Clinico San Carlos, Madrid, Spain
    Arthritis Rheum 59:489-96. 2008
    ..To identify factors associated with poor outcome in temporary work disability (TWD) due to musculoskeletal disorders (MSDs)...
  8. ncbi request reprint Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population
    Lydia Abasolo
    Rheumatology Department, Hospital Clinico San Carlos, Madrid, Spain
    Semin Arthritis Rheum 37:388-97. 2008
    ..To estimate the prevalence, incidence, mortality, and predictors of cancer in patients with rheumatoid arthritis (RA)...
  9. ncbi request reprint Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis
    Alejandro Balsa
    Rheumatology Unit, Hospital Universitario La Paz, Madrid, Spain
    J Rheumatol 31:40-6. 2004
    ....
  10. pmc All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
    Loreto Carmona
    Research Unit, Spanish Foundation of Rheumatology, Madrid, Spain
    Ann Rheum Dis 66:880-5. 2007
    ..Mortality is increased in rheumatoid arthritis (RA), mainly because of cardiovascular (CV) events, cancer and infections. Recent data suggest that treatment with tumour necrosis factor (TNF) antagonists may affect this trend...
  11. ncbi request reprint Increased risk of tuberculosis in patients with rheumatoid arthritis
    Loreto Carmona
    Hospital Clinico San Carlos, Madrid, Spain
    J Rheumatol 30:1436-9. 2003
    ..To quantify the risk of tuberculosis (TB) in an unselected sample of patients with rheumatoid arthritis (RA) compared to the risk in the general population...
  12. doi request reprint Effectiveness of a clinical practice intervention in early rheumatoid arthritis
    Miguel Angel Descalzo
    Sociedad Española de Reumatología, Madrid, Spain
    Arthritis Care Res (Hoboken) 64:321-30. 2012
    ..To compare the outcome of early rheumatoid arthritis (RA) patients in a country where early clinics were established versus the outcome of patients in nonprotocolized clinics...
  13. ncbi request reprint Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy
    Leticia Leon
    From the Rheumatology Unit, Instituto de Investigacion Sanitaria, Hospital Clínico San Carlos Universidad Camilo Jose Cela Agencia Española de Medicamentos y Productos Sanitarios Rheumatology Unit, Hospital Clinico San Carlos, Madrid, Spain
    J Rheumatol 40:1850-5. 2013
    ..To analyze sociodemographic and clinic-related factors associated with the use of orthopedic surgical procedures in rheumatoid arthritis (RA), focusing on the potential role of new biologic therapies...
  14. ncbi request reprint Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients
    Jesús Maese
    Grupo de Trabajo de Reumatología Basada en la Evidencia, Sociedad Española de Reumatología, Madrid, Spain
    Reumatol Clin 8:236-42. 2012
    ..The quality of care could benefit from the application of appropriate clinical practice standards; we present a study on the variability of clinical practice...
  15. pmc Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort
    Isidoro Gonzalez-Alvaro
    Rheumatology Service, Hospital Universitario de la Princesa, Madrid, Spain
    Arthritis Res Ther 10:R138. 2008
    ..In the present work we estimate the effect of these factors on disease activity and function in patients with rheumatoid arthritis at the beginning of the new century...
  16. doi request reprint Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease
    Estibaliz Loza
    Rheumatology Unit, Hospital Clinico San Carlos, Madrid, Spain
    Semin Arthritis Rheum 38:312-9. 2009
    ....
  17. ncbi request reprint Burden of disease across chronic diseases: a health survey that measured prevalence, function, and quality of life
    Estibaliz Loza
    Rheumatology Unit, Hospital Clinico San Carlos, and the Research Unit, Spanish Foundation of Rheumatology, Madrid, Spain
    J Rheumatol 35:159-65. 2008
    ..To assess health related quality of life (HRQOL) and functional ability across groups of chronic diseases in Spain...
  18. ncbi request reprint Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature
    Lydia Abasolo
    Rheumatology Unit, Fundación para la Investigación Biomédica, Instituto de Investigacion Sanitaria, Hospital Clinico San Carlos, Madrid, Spain
    Reumatol Clin 9:226-8. 2013
    ..Patients with rheumatoid arthritis (RA) complain that weather conditions aggravate their symptoms. We investigated the short-term effects of weather conditions on worsening of RA and determined possible seasonal fluctuations...
  19. pmc Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
    Loreto Carmona
    Research Unit, Spanish Society of Rheumatology, Madrid, Spain Marques de Duero 5, 28001 Madrid, Spain
    Arthritis Res Ther 8:R72. 2006
    ..Because chronic therapy is necessary, continual review of this issue is necessary...
  20. doi request reprint Prognostic factors for long-term work disability due to musculoskeletal disorders
    Lydia Abasolo
    Rheumatology Department, Servicio de Reumatologia, Hospital Clinico San Carlos, Calle Profesor Martín Lagos s n, 28040 Madrid, Spain
    Rheumatol Int 32:3831-9. 2012
    ..Sociodemographic, work-related, occupational factors, and other clinical factors, some of which are modifiable, may explain the development of long-term work disability related to MSDs...
  21. doi request reprint Economic burden of knee and hip osteoarthritis in Spain
    Estibaliz Loza
    Hospital Clinico San Carlos, Madrid, Spain
    Arthritis Rheum 61:158-65. 2009
    ..To estimate the direct and indirect osteoarthritis (OA)-attributable costs and predictors of costs of knee and hip OA in Spain...
  22. doi request reprint A meta-analysis of mortality in rheumatic diseases
    Esther Toledano
    Rheumatology Department, Hospital Clinico San Carlos, Madrid, Spain
    Reumatol Clin 8:334-41. 2012
    ..Data reporting mortality in rheumatic diseases vary widely. The objective of this systematic review and meta-analysis of published data is to provide an accurate overview of the current risk of mortality in rheumatic diseases...
  23. doi request reprint Clinical composite measures of disease activity for diagnosis and followup of undifferentiated peripheral inflammatory arthritis: a systematic review
    Isabel Castrejón
    Hospital La Princesa, C Diego de Leon 62, Madrid, Spain
    J Rheumatol Suppl 87:48-53. 2011
    ..To critically appraise the validity of activity indices used in the followup of patients with undifferentiated peripheral inflammatory arthritis (UPIA)...
  24. doi request reprint Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital
    Beatriz E Joven
    Hospital Universitario 12 de Octubre, Servicio de Reumatologia, Madrid, Spain
    Semin Arthritis Rheum 39:285-93. 2010
    ..To analyze the causes of death, survival, and risk factors for mortality in a large series of Spanish systemic sclerosis (SSc) patients followed over the last 25 years in a tertiary care university hospital...
  25. ncbi request reprint Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists
    Loreto Carmona
    Institute for Musculoskeletal Health, Madrid, Spain
    Clin Exp Rheumatol 31:883-8. 2013
    ..To test the reliability of the Berlin MRI scoring method and the effect of a calibration exercise on the score's reliability among untrained readers in MRI examinations of patients with established ankylosing spondylitis (AS)...
  26. ncbi request reprint Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
    Loreto Carmona
    Spanish Society of Rheumatology, Madrid, Spain
    Arthritis Rheum 52:1766-72. 2005
    ..To investigate the impact of official recommendations regarding the management of latent tuberculosis (TB) infection on the rate of active TB in patients receiving treatment with tumor necrosis factor (TNF) antagonists...
  27. doi request reprint A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: the Esperanza Program
    Santiago Muñoz-Fernández
    Rheumatology Unit, Hospital Infanta Sofia, San Sebastian de los Reyes, Madrid, Spain
    Ann Rheum Dis 70:827-30. 2011
    ..To evaluate the performance of a healthcare programme in early spondyloarthritis (SpA)...
  28. ncbi request reprint [Systematic review: are major opioids effective in the treatment of musculoskeletal pain?]
    Lydia Abasolo
    Servicio de Reumatologia, Hospital Clinico San Carlos, Madrid, Espana
    Med Clin (Barc) 128:291-301. 2007
    ..To evaluate the efficacy of major opioids in the treatment of musculoskeletal pain...
  29. doi request reprint Development and validation of a new disease activity index as a numerical sum of four variables in patients with early arthritis
    Isabel Castrejón
    NYU Hospital for Joint Diseases, New York, USA
    Arthritis Care Res (Hoboken) 65:518-25. 2013
    ..To describe the development and validation of a disease activity index in early arthritis that can be easily applied in daily practice and clinical research...
  30. ncbi request reprint Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review
    Gloria Candelas
    Rheumatology Unit, Hospital Clinico de San Carlos, Madrid, Spain
    Clin Exp Rheumatol 30:954-61. 2012
    ..This paper aims to examine the risk of nephrolithiasis in patients with osteoporosis and calcium supplementation...
  31. ncbi request reprint Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression
    Esperanza Naredo
    Hospital Severo Ochoa, Madrid, Spain
    Arthritis Rheum 57:116-24. 2007
    ....
  32. doi request reprint Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis
    Esperanza Pato
    Rheumatology Department, Hospital Clinico San Carlos, Madrid, Spain
    Semin Arthritis Rheum 40:314-23. 2011
    ..To analyze the effectiveness of immunosuppressants and biological therapies in autoimmune posterior uveitis, chronic anterior uveitis associated with juvenile idiopathic arthritis, and macular edema...
  33. ncbi request reprint Survival, mortality and causes of death in inflammatory myopathies
    Carmen Torres
    Hospital 12 de Octubre, Servicio de Reumatologia, Madrid, Spain
    Autoimmunity 39:205-15. 2006
    ..To investigate the causes of death, survival and clinical factors associated with mortality, in a group of Spanish patients with inflammatory myopathies (IM) followed in the same University Hospital during a 25 year period...
  34. ncbi request reprint Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0
    Tatiana Cobo-Ibáñez
    Rheumatology Department, Hospital Universitario Infanta Sofía, Paseo de Europa 34, San Sebastian de los Reyes, 28702, Madrid, Spain
    Rheumatol Int 34:953-61. 2014
    ..When evaluating the risk/benefit ratio of off-label medications in ICTD patients, age, comorbidities and corticoid use should carefully be taken into account, applying adequate preventive measures. ..
  35. ncbi request reprint Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis
    Isidoro Gonzalez-Alvaro
    Department of Rheumatology, Hospital Universitario de la Princesa, Madrid, Spain
    J Rheumatol 30:697-704. 2003
    ..To determine the adequacy of disease modifying antirheumatic drug (DMARD) prescription to disease activity in patients with rheumatoid arthritis (RA) and to assess whether the reasons for DMARD discontinuation agree with published evidence...
  36. ncbi request reprint Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study
    Cristina Lajas
    Hospital Clinico San Carlos, Madrid, Spain
    Arthritis Rheum 49:64-70. 2003
    ..To analyze the annual cost of rheumatoid arthritis (RA) and its predictive factors...
  37. doi request reprint Databases and registers: useful tools for research, no studies
    Rafael J Curbelo
    Instituto de Salud Musculoesquelética, INMUSC, Ofelia Nieto, 10, 28039, Madrid, Spain
    Rheumatol Int 34:447-52. 2014
    ....
  38. ncbi request reprint A health system program to reduce work disability related to musculoskeletal disorders
    Lydia Abasolo
    Hospital Clinico San Carlos, Hospital Ramon y Cajal, Madrid, Spain
    Ann Intern Med 143:404-14. 2005
    ..Musculoskeletal disorders (MSDs) are a frequent cause of work disability, accounting for productivity losses in industrialized societies equivalent to 1.3% of the U.S. gross national product...
  39. ncbi request reprint How good is to switch between biologics? A systematic review of the literature
    Loreto Carmona
    Unidad de Investigacion, Fundación Española de Reumatología, Madrid, Spain
    Acta Reumatol Port 32:113-28. 2007
    ..Despite the biological rationale for switching between TNF-antagonists, there is not a definitive answer from a clinical point of view...
  40. doi request reprint Diagnostic and prognostic value of genetics in undifferentiated peripheral inflammatory arthritis: a systematic review
    Lucía Silva-Fernández
    Servicio de Reumatologia, Hospital Universitario Puerta de Hierro Majadahonda, Joaquín Rodrigo 2, Majadahonda, Madrid, Spain
    J Rheumatol Suppl 87:38-44. 2011
    ..To evaluate the diagnostic and prognostic utility of genetic testing in undifferentiated peripheral inflammatory arthritis (UPIA)...
  41. ncbi request reprint [Biobadaser 2.0: analysis and trends in 2009]
    Miguel Angel Descalzo
    Unidad de Investigacion, Sociedad Española de Reumatología, Madrid, Espana
    Reumatol Clin 6:240-3. 2010
    ..To update the information on long-term safety of biological therapies used for the treatment of rheumatic diseases...